Trial Profile
A retrospective study evaluating the efficacy of Metyrapone in treating Cushing's Syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2017
Price :
$35
*
At a glance
- Drugs Metyrapone (Primary)
- Indications Cushing syndrome
- Focus Therapeutic Use
- 08 Nov 2017 New trial record